Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: GlobeNewswire
SEATTLE, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences. BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UTParticipating on Tuesday, February 10, 2026TD Cowen 46th Annual Health Care Conference in Boston, MAFireside chat on Monday, March 2, 2026, at 11:50 a.m. Eastern Time Interested parties may access live and archived webcasts of the session on the “Investors” section of the company website at: www.adaptivebiotech.com. About Adaptive Biotechnologies Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disea
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies (NASDAQ:ADPT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ADPT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
- Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $21.00. They now have an "overweight" rating on the stock.MarketBeat
- Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.MarketBeat
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 2/6/26 - Form 4
- 2/5/26 - Form 8-K
- 2/4/26 - Form 4
- ADPT's page on the SEC website